Non-U.S. Clinical Trials, Regulatory Submissions, Recommendations And Approvals: November 2003 Dec. 15, 2003
Merck, Actelion's Renin Inhibitors: Hypertension's Next Potential Fix? Dec. 15, 2003 By Randy Osborne